Results

Total Results: 1,166 records

Showing results for "loss".

61. Cannabis-App-G-Table-Surveillance-Report-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-g-table-surveillance-report-2.xlsx
    February 16, 2022 - Is There Important Differential Loss to Followup or Overall High Loss to Followup or Missing Data?

62. Cannabis-Annual-Update2-Table-F1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-f1.xlsx
    March 13, 2023 - Is There Important Differential Loss to Followup or Overall High Loss to Followup or Missing Data?

63. Cannabis-2022-Surv-Rep-3-App-G (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-app-G.xlsx
    January 01, 2022 - Is There Important Differential Loss to Followup or Overall High Loss to Followup or Missing Data?

64. Cannabis-2022-Update-Surv-Rep-1-Apps-G1-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-apps-G1-2.xlsx
    January 01, 2022 - Is There Important Differential Loss to Followup or Overall High Loss to Followup or Missing Data?

65. Cer-250-Cannabis-Tables-F1-F2-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-f1-f2-2022-update_0.xlsx
    January 01, 2022 - Is There Important Differential Loss to Followup or Overall High Loss to Followup or Missing Data?

66. Cannabis-App-G-Table-Surveillance-Report-2 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-g-table-surveillance-report-2_0.xlsx
    February 16, 2022 - Is There Important Differential Loss to Followup or Overall High Loss to Followup or Missing Data?

67. Abnormal-Uterine-Bleeding Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
    March 01, 2013 - ePercent change in menstrual blood loss measured by the pictorial blood loss assessment chart. 13 … Menstrual blood loss—a population study. … , menstrual blood loss and pictorial blood loss assessment charts. … The effects of mefenamic acid and norethisterone on measured menstrual blood loss. … Hair loss with use of the levonorgestrel intrauterine device.

68. Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/ptsd-adult-treatment-update/research-2018
    May 17, 2018 - therapies with mixed components are effective to decrease PTSD symptoms and depression symptoms, and for loss … desensitization reprocessing are most likely effective to decrease PTSD and  depression symptoms, and for loss … Several psychological treatments were associated with the reduction of PTSD symptoms and loss of PTSD

69. Management and Outcomes of Binge-Eating Disorder in Adults: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
    May 01, 2016 - The review assessed psychological interventions, behavioral weight-loss treatment, and pharmacological … frequency and increased binge- eating abstinence.† �� CBT has been compared with behavioral weight-loss … d Lisdexamphetimine is not indicated by the FDA for weight loss. … The FDA notes that use of other sympathomimetic drugs for weight loss has been associated with serious … restriction and increased physical activity, to promote weight loss.

70. Glaucoma-Screening Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
    April 01, 2012 - people worldwide.1,2 Although glaucoma may be characterized by optic nerve damage, visual field loss … for confirming diagnosis.3 Damage is irreversible, so early detection can prevent severe vision loss … KQ5b: How do optic nerve damage and visual field loss vary when comparing different screening-based … and 90 percent for both field loss and optic nerve damage). … only; 67 percent/79 percent, both glaucomatous optic nerve appearance and visual field loss.

71. Disposition of Comments Report for Otitis Media With Effusion (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
    May 04, 2013 - Should at least qualify “hearing loss” with “severe, protracted.” … As recommended, we qualified hearing loss as severe and protracted. … The marginal consequences of small hearing loss may be greater in these children. … We have deleted the phrase “with respect to mild or moderate hearing loss.” … Grammatical outcomes of 3 & 6 year old children with mild to severe hearing loss.

72. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/our-topic-of-nomination-is-postpartum-hemorrhage-the-following-is-a-list-of-clinical-questions-practitioners-consider-when-managing-such-cases-what-should-be-considered-in-the-initial-evaluation-of-a-patient-with-excessive-bl
    October 01, 2013 - What is the best approach to managing excessive blood loss in the postpartum period once the patient's … recommendations -Comparing effectiveness of different oxytocin agents -Methods on estimating blood loss … Sequelae include adult respiratory distress syndrome, coagulopathy, shock, loss of fertility, and pituitary

73. Cannabis-2023-Surv-Rep-1-App-G (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-G.xlsx
    January 01, 2023 - Is There Important Differential Loss to Followup or Overall High Loss to Followup or Missing Data?

74. Cannabis-2022-Surv-Rep-4-Tables-G1-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-G1-2.xlsx
    January 01, 2022 - Is There Important Differential Loss to Followup or Overall High Loss to Followup or Missing Data?

75. Cannabis-2023-Surv-Rep-4-Tables-F1-F-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-F1-F-2.xlsx
    January 01, 2023 - Is There Important Differential Loss to Followup or Overall High Loss to Followup or Missing Data?

76. Glaucoma-Screening Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_surveillance.pdf
    January 01, 2013 - and 90 percent for both field loss and optic nerve damage). … only; 67 percent/79 percent, both glaucomatous optic nerve appearance and visual field loss. … only; 24 percent/97 percent, both glaucomatous optic nerve appearance and visual field loss. … and 90 percent for both field loss and optic nerve damage). … only; 67 percent/79 percent, both glaucomatous optic nerve appearance and visual field loss.

77. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research
    September 25, 2013 - Under a dominant model, loss-of-function alleles were associated with higher on-clopidogrel platelet … Associations were nonstatistically significant in meta-analyses of loss-of-function alleles and all-cause … Conclusions We found evidence to support an association between loss-of-function CYP2C19 variants and

78. Evidence Summary: Comparative Effectiveness Review No. 245_Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-evidence-summary-updated.pdf
    July 01, 2021 - IBR either before or after radiation therapy probably results in comparable risk of implant failure/loss … o ADM use probably increases the risk of implant failure/loss or need for explant surgery (Moderate … We found that IBR probably results in comparable risk of implant failure/loss or need for explant surgery … Use versus nonuse of human ADMs during IBR: ADM use probably increases the risk of implant failure/loss … Implant failure/loss or needing explant . ~~ ? ? ◆◆ with ADM . Capsular contracture . N/P ? ?

79. Evidence Summary: Comparative Effectiveness Review No. 245_Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-evidence-summary_0.pdf
    July 01, 2021 - IBR either before or after radiation therapy probably results in comparable risk of implant failure/loss … o ADM use probably increases the risk of implant failure/loss or need for explant surgery (Moderate … We found that IBR probably results in comparable risk of implant failure/loss or need for explant surgery … Use versus nonuse of human ADMs during IBR: ADM use probably increases the risk of implant failure/loss … Implant failure/loss or needing explant . ~ ? ? ◆◆ with ADM . Capsular contracture . N/P ? ?

80. Evidence Summary: Comparative Effectiveness Review No. 245_Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-evidence-summary-updated-1.pdf
    October 01, 2021 - IBR either before or after radiation therapy probably results in comparable risk of implant failure/loss … o ADM use probably increases the risk of implant failure/loss or need for explant surgery (Moderate … We found that IBR probably results in comparable risk of implant failure/loss or need for explant surgery … Use versus nonuse of human ADMs during IBR: ADM use probably increases the risk of implant failure/loss … Implant failure/loss or needing explant . ~~ ? ? ◆◆ with ADM . Capsular contracture . N/P ? ?